Satomi Shimura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A single site study to investigate the current prevalence of anti-hepatitis C virus antibody among substance use disorder patients in Hiroshima-Insufficient testing and diagnosis.
Journal: Neuropsychopharmacology reports
Published: February 03, 2023
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.
Journal: Cell chemical biology
Published: December 09, 2017
MA026, an anti-hepatitis C virus compound, opens tight junctions of the epithelial cell membrane.
Journal: The Journal of antibiotics
Published: October 27, 2016
Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.
Journal: Journal of hepatology
Published: April 19, 2016
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Journal: Journal of virology
Published: June 23, 2015
Total synthesis of (+)-Sch 725680: inhibitor of mammalian A-, B-, and Y-family DNA polymerases.
Journal: Organic letters
Published: August 30, 2012
The antitumor agent doxorubicin binds to Fanconi anemia group F protein.
Journal: Bioorganic & medicinal chemistry
Published: July 20, 2012
Exploration of the binding proteins of perfluorooctane sulfonate by a T7 phage display screen.
Journal: Bioorganic & medicinal chemistry
Published: April 11, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026